Delivering results that matter

Across our diverse practices, we have consistently delivered remarkable outcomes for our clients. Take a closer look at how we partner with clients to help them realize their goals.

Achievement > Keyword
Plane wing flying over a sunset

Filter By:

Achievement > Capability
See all filters
Applied Filters:

Achievement

Troutman Pepper Secures Defense Verdict for Johnson & Johnson in Hip Implant Case

Troutman Pepper was part of a national trial team that secured a defense verdict on behalf of Johnson & Johnson …

Achievement

Troutman Pepper Helps Notch Full Defense Verdict for Johnson & Johnson in Hip Implant Case

Troutman Pepper was part of a national trial team that secured a defense verdict in a jury trial involving the …

Achievement

Troutman Pepper Defends Pharmaceutical Company Against ‘Reverse Payment’ Antitrust Litigation

For several years, Troutman Pepper has defended a global pharmaceutical company as lead counsel in a series of cases challenging …

Achievement

Troutman Pepper Helps Secure Another Jury Verdict for Johnson & Johnson in Pelvic Mesh Trial

Troutman Pepper was part of a national trial team that secured a defense verdict after a nine-day jury trial in …

Achievement

Troutman Pepper Helps Secure Defense Verdict for Johnson & Johnson After 12-day Jury Trial

Troutman Pepper was part of a national trial team that secured a defense verdict after a 12-day jury trial in …

Achievement

Troutman Pepper Helps Secure Defense Jury Verdict for Global Pharmaceutical and Medical Device Company

Troutman Pepper was part of a national trial team that notched a defense verdict following a 10-day jury trial in …

Achievement

Locke Lord Chicago Team Secures Decision in Favor of Broad Institute From U.S. Patent and Trademark Office in CRISPR Patent Interference

Team secured a USPTO ruling confirming the Broad Institute’s CRISPR-Cas9 genome editing patents — a landmark win for life sciences IP clients.

Achievement

Providence-Led Team Represents Biohaven Pharmaceutical and BioShin Limited in BioShin’s $60 Million Series A Preferred Equity Financing

A Locke Lord team led by Douglas Gray, Kathrine Morin (Providence) and Ralph Loren (Boston), represented Biohaven Pharmaceutical Holding Company …

Back to the top